Encoded Therapeutics Raises $275M to Advance ETX101 Through Pivotal Development

Encoded Therapeutics has raised $275 million in Series F financing to advance its lead genetic medicine ETX101 through pivotal development... Read More
The post Encoded Therapeutics Raises $275M to Advance ETX101 Through Pivotal Development appeared first on citybiz.
